Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Supplementary Fig. 1 shows the results of the Wald ratio method with a single SNP as an exposure tool.Mendelian randomization resultsExposureMethodsNumber of SNPsDiscovery CohortReplication CohortOR95% CIPOR95% CIPCalciumInverse-variance weighted61.2700.706 to 2.2840.421.1150.689 to 1.8050.66Weighted median61.1150.631 to 1.9700.711.0080.606 to 1.6760.98Weighted mode61.0560.561 to 1.9870.870.9870.579 to 1.6820.96MR Egger61.1070.319 to 3.8410.451.0860.486 to 2.4300.43PhosphateInverse-variance weighted30.6640.344 to 1.2830.220.6620.374 to 1.1710.16Weighted median30.7460.356 to 1.5630.440.6870.337 to 1.4000.30Weighted mode30.8170.364 to 1.8370.670.7390.323 to 1.6900.55MR Egger30.3550 to 19632.0830.340.2970.010 to 8.8330.1925OH-VitDInverse-variance weighted61.4090.881 to 2.2530.150.8240.499 to 1.3610.45Weighted median61.2200.830 to 1.7930.310.7120.510 to 0.9940.05Weighted mode61.2100.821 to 1.7830.380.7040.509 to 0.9740.09MR Egger61.0020.529 to 1.9000.490.5430.321 to 0.9180.01PTHInverse-variance weighted31.7370.924 to 3.2660.091.6500.931 to 2.9250.09Weighted median31.5660.768 to 3.1950.221.8180.983 to 3.3610.06Weighted mode31.3170.543 to 3.1930.601.8250.886 to 3.7600.24MR Egger32.9190.301 to 28.2820.173.1680.470 to 21.3560.12FGF23Inverse-variance weighted43.0811.649 to 5.7604.21 × 10−42.2801.461 to 3.5582.82 × 10−4Weighted median43.0911.733 to 5.5141.76 × 10−42.6251.530 to 4.5024.20 × 10−4Weighted mode43.1381.639 to 6.0060.042.6641.399 to 5.0710.06MR Egger43.2630.326 to 32.6740.152.0910.833 to 5.2480.05SNP single nucleotide polymorphism, OR odds ratio, CI confidence interval, 25OH-VitD 25-hydroxyvitamin D, PTH parathyroid hormone, FGF23 fibroblast growth factor 23.CAVS calcific aortic valve stenosis, PTH parathyroid hormone, FGF23 fibroblast growth factor 23, SNP single nucleotide polymorphism.

Source: Primary analysis. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis reported · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In this study, we employed a systematic pipeline combining Mendelian randomization (MR), Steiger directionality test, colocalization analysis, protein-protein network, and enrichment analysis to investigate the causal effect of mineral metabolism on CAVS.

Source: Abstract.

To validate our findings through replication analysis, we used GWAS data for CAVS from a large-scale GWAS meta-analysis, comprising 13,765 cases and 640,102 controls from 10 European ancestry cohorts.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

Genetic instrumental-variable study · npj Cardiovascular Health · 2024

Original publication title

Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

Qinghao Zhao; Wenchang Nie; Jiaming Dong; Bowen Zhang; Gongzheng Tang; Shenda Hong; Jian Liu

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Disorders of mineral metabolism, including elevated levels of serum calcium, phosphate, 25-hydroxyvitamin D (25OH-VitD), parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23), have been reported in patients with calcific aortic valve stenosis (CAVS). However, evidence of the causal role of mineral metabolism in CAVS is still lacking. In this study, we employed a systematic pipeline combining Mendelian randomization (MR), Steiger directionality test, colocalization analysis, protein-protein network, and enrichment analysis to investigate the causal effect of mineral metabolism on CAVS.

Genome-wide association study (GWAS) and protein quantitative trait loci data for mineral metabolism markers were extracted from large-scale meta-analyses. Summary statistics for CAVS were obtained from two independent GWAS datasets as discovery and replication cohorts (n = 374,277 and 653,867). In MR analysis, genetic mimicry of serum FGF23 elevation was associated with increased CAVS risk [ORdiscovery = 3.081 (1.649 to 5.760), Pdiscovery = 4.21 × 10−4; ORreplication = 2.280 (1.461 to 3.558), Preplication = 2.82 × 10−4] without evidence of reverse causation (Psteiger= 7.21 × 10−98).

Strong colocalisation association with CAVS was observed for FGF23 expression in the blood (PP.H4 = 0.96). Additionally, we identified some protein-protein interactions between FGF23 and known CAVS-associated genes. Serum calcium, phosphate, 25OH-VitD, and PTH failed to show causal effects on CAVS at Bonferroni-corrected significance (all P > 0.05/5 = 0.01). In conclusion, elevated serum FGF23 level may act as a causal risk factor for CAVS, and its mechanism of action in CAVS development may be independent of its function in regulating mineral metabolism.

Hence, FGF23 may serve as a circulating marker and a promising preventive target for CAVS, warranting further investigation.

Authors’ abstract

Disorders of mineral metabolism, including elevated levels of serum calcium, phosphate, 25-hydroxyvitamin D (25OH-VitD), parathyroid hormone (PTH), and fibroblast growth factor 23 (FGF23), have been reported in patients with calcific aortic valve stenosis (CAVS). However, evidence of the causal role of mineral metabolism in CAVS is still lacking. In this study, we employed a systematic pipeline combining Mendelian randomization (MR), Steiger directionality test, colocalization analysis, protein-protein network, and enrichment analysis to investigate the causal effect of mineral metabolism on CAVS.

Genome-wide association study (GWAS) and protein quantitative trait loci data for mineral metabolism markers were extracted from large-scale meta-analyses. Summary statistics for CAVS were obtained from two independent GWAS datasets as discovery and replication cohorts (n = 374,277 and 653,867). In MR analysis, genetic mimicry of serum FGF23 elevation was associated with increased CAVS risk [ORdiscovery = 3.081 (1.649 to 5.760), Pdiscovery = 4.21 × 10−4; ORreplication = 2.280 (1.461 to 3.558), Preplication = 2.82 × 10−4] without evidence of reverse causation (Psteiger= 7.21 × 10−98).

Strong colocalisation association with CAVS was observed for FGF23 expression in the blood (PP.H4 = 0.96). Additionally, we identified some protein-protein interactions between FGF23 and known CAVS-associated genes. Serum calcium, phosphate, 25OH-VitD, and PTH failed to show causal effects on CAVS at Bonferroni-corrected significance (all P > 0.05/5 = 0.01). In conclusion, elevated serum FGF23 level may act as a causal risk factor for CAVS, and its mechanism of action in CAVS development may be independent of its function in regulating mineral metabolism.

Hence, FGF23 may serve as a circulating marker and a promising preventive target for CAVS, warranting further investigation.

Publication and source details

Original title: Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis

Qinghao Zhao; Wenchang Nie; Jiaming Dong; Bowen Zhang; Gongzheng Tang; Shenda Hong; Jian Liu

npj Cardiovascular Health · 2024

© The Author(s) 20242024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Peking University People’s Hospital Scientific Research Development FundsRDJP2022-39Clinical Medicine Plus X: Young Scholars Project of Peking University, the Fundamental Research Funds for the Central Universitieshttp://dx.doi.org/10.13039/501100001809National Natural Science Foundation of ChinaNo. 81970294 and No.11832003

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:33:56.800756+00:00

DOI: 10.1038/s44325-024-00013-x · PMC12912326